Interestingly, in patients with HCC, immune checkpoint-related molecules (PD-1, PD-L1, and CTLA-4) are usually overexpressed due to long-term chronic inflammation, resulting in the apoptosis of CD8+ T cells and a decreased activity of these cells against tumor (43, 44). The gene discussed is CD8A; the disease is hepatocellular carcinoma.